Xencor Files For IPO
socalTECH
OCTOBER 11, 2013
Monrovia, California-based biopharmaceuticals developer Xencor has filed for an IPO, saying in a filing this morning that it looking to raise up to $69.0M Xencor, which is led by Bassil Dahiyat, develops engineered monoclonal antibodies, which are being used to treat autoimmune and allergic diseases, cancer and other conditions.
Let's personalize your content